Cargando…

A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients

OBJECTIVE: Oxidative stress is involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Corticosteroid fails to suppress inflammation and oxidative stress due to steroid resistance. Theophylline has an effect on histone deacetylase (HDAC) activity and improves steroid sensitivit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjani, R., Vinotha, A. T. Sathiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680646/
https://www.ncbi.nlm.nih.gov/pubmed/29184823
http://dx.doi.org/10.4103/jphi.JPHI_58_17
_version_ 1783277803772313600
author Ranjani, R.
Vinotha, A. T. Sathiya
author_facet Ranjani, R.
Vinotha, A. T. Sathiya
author_sort Ranjani, R.
collection PubMed
description OBJECTIVE: Oxidative stress is involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Corticosteroid fails to suppress inflammation and oxidative stress due to steroid resistance. Theophylline has an effect on histone deacetylase (HDAC) activity and improves steroid sensitivity in COPD. Given changes in oxidative stress associated with diminished corticosteroid effects, a clinical study in which antioxidants and free radicals are estimated can suggest a correlation between antioxidants, theophylline, and corticosteroid sensitivity. MATERIALS AND METHODS: A randomized controlled study was conducted in 60 participants divided into 4 groups: Group I (controls) - 15 normal healthy volunteers, Group II - COPD patients who received theophylline 300 mg + salbutamol 8 mg, Group III - patients who inhaled budesonide 400 μg + salbutamol 8 mg, and Group IV – theophylline 300 mg + inhaled budesonide 400 μg + salbutamol 8 mg 12 weeks. Blood samples were collected at the time of diagnosis and at 4-week interval for 3 months from all the groups and antioxidant parameters, spirometric % forced expiratory volume in 1 s (FEV(1)) were measured. RESULTS: The mean difference between groups was analyzed using one-way ANOVA. There was a significant increase in antioxidant enzymes such as catalase, glutathione (GSH) serum transferase, (P < 0.05), reduced GSH, and superoxide dismutase (P < 0.01) and a significant decrease in lipid peroxidation (P < 0.01) at 12 weeks of the study period. Postbronchodilator FEV(1) values have also shown a significant increase at 12 weeks (P < 0.01). CONCLUSION: Theophylline increases the expression and activity of HDAC and improves steroid sensitivity thereby decreases oxidative stress. Hence, novel therapeutic strategy is therefore the reversal of this corticosteroid resistance by increasing the expression and activity of HDAC achieved using corticosteroids along with theophylline.
format Online
Article
Text
id pubmed-5680646
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56806462017-11-28 A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients Ranjani, R. Vinotha, A. T. Sathiya Int J Pharm Investig Original Research Article OBJECTIVE: Oxidative stress is involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Corticosteroid fails to suppress inflammation and oxidative stress due to steroid resistance. Theophylline has an effect on histone deacetylase (HDAC) activity and improves steroid sensitivity in COPD. Given changes in oxidative stress associated with diminished corticosteroid effects, a clinical study in which antioxidants and free radicals are estimated can suggest a correlation between antioxidants, theophylline, and corticosteroid sensitivity. MATERIALS AND METHODS: A randomized controlled study was conducted in 60 participants divided into 4 groups: Group I (controls) - 15 normal healthy volunteers, Group II - COPD patients who received theophylline 300 mg + salbutamol 8 mg, Group III - patients who inhaled budesonide 400 μg + salbutamol 8 mg, and Group IV – theophylline 300 mg + inhaled budesonide 400 μg + salbutamol 8 mg 12 weeks. Blood samples were collected at the time of diagnosis and at 4-week interval for 3 months from all the groups and antioxidant parameters, spirometric % forced expiratory volume in 1 s (FEV(1)) were measured. RESULTS: The mean difference between groups was analyzed using one-way ANOVA. There was a significant increase in antioxidant enzymes such as catalase, glutathione (GSH) serum transferase, (P < 0.05), reduced GSH, and superoxide dismutase (P < 0.01) and a significant decrease in lipid peroxidation (P < 0.01) at 12 weeks of the study period. Postbronchodilator FEV(1) values have also shown a significant increase at 12 weeks (P < 0.01). CONCLUSION: Theophylline increases the expression and activity of HDAC and improves steroid sensitivity thereby decreases oxidative stress. Hence, novel therapeutic strategy is therefore the reversal of this corticosteroid resistance by increasing the expression and activity of HDAC achieved using corticosteroids along with theophylline. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5680646/ /pubmed/29184823 http://dx.doi.org/10.4103/jphi.JPHI_58_17 Text en Copyright: © 2017 International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Research Article
Ranjani, R.
Vinotha, A. T. Sathiya
A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients
title A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients
title_full A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients
title_fullStr A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients
title_full_unstemmed A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients
title_short A prospective randomized controlled study: Theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients
title_sort prospective randomized controlled study: theophylline on oxidative stress and steroid sensitivity in chronic obstructive pulmonary disease patients
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680646/
https://www.ncbi.nlm.nih.gov/pubmed/29184823
http://dx.doi.org/10.4103/jphi.JPHI_58_17
work_keys_str_mv AT ranjanir aprospectiverandomizedcontrolledstudytheophyllineonoxidativestressandsteroidsensitivityinchronicobstructivepulmonarydiseasepatients
AT vinothaatsathiya aprospectiverandomizedcontrolledstudytheophyllineonoxidativestressandsteroidsensitivityinchronicobstructivepulmonarydiseasepatients
AT ranjanir prospectiverandomizedcontrolledstudytheophyllineonoxidativestressandsteroidsensitivityinchronicobstructivepulmonarydiseasepatients
AT vinothaatsathiya prospectiverandomizedcontrolledstudytheophyllineonoxidativestressandsteroidsensitivityinchronicobstructivepulmonarydiseasepatients